Fig. 4From: Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinomaKaplan–Meier analysis of overall survival. The log-rank test did not show significant differences between responders and non-responders classified according to RECIST 1.1 (P = 0.0722)Back to article page